Skip to content

Sage Therapeutics, Inc.: filings

Every Sage Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 45 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2025-07-30fiscal Q2 2025361030000950170-25-100276
10-Q2025-04-29fiscal Q1 202536750000950170-25-060158
10-K2025-02-11fiscal FY 2024441120000950170-25-017909
10-Q2024-10-29fiscal Q3 2024371070000950170-24-118256
10-Q2024-07-31fiscal Q2 2024361020000950170-24-088593
10-Q2024-04-25fiscal Q1 202436740000950170-24-047919
10-K2024-02-14fiscal FY 2023441110000950170-24-014934
10-Q2023-11-07fiscal Q3 2023371070000950170-23-059750
10-Q2023-08-07fiscal Q2 2023361020000950170-23-038739
10-Q2023-05-02fiscal Q1 202335720000950170-23-016436
10-K2023-02-16fiscal FY 2022431100000950170-23-002964
10-Q2022-11-08fiscal Q3 2022361060000950170-22-022901
10-Q2022-08-02fiscal Q2 2022361020001564590-22-027331
10-Q2022-05-03fiscal Q1 202236740001564590-22-017225
10-K2022-02-24fiscal FY 2021441120001564590-22-006495
10-Q2021-11-02fiscal Q3 2021361060001564590-21-053304
10-Q2021-08-03fiscal Q2 2021361020001564590-21-039953
10-Q2021-05-04fiscal Q1 202135710001564590-21-022988
10-K2021-02-24fiscal FY 2020441480001564590-21-007819
10-Q2020-11-05fiscal Q3 2020371060001564590-20-050861
10-Q2020-08-10fiscal Q2 2020371020001564590-20-038597
10-Q2020-05-07fiscal Q1 202037750001564590-20-022891
10-K2020-02-27fiscal FY 2019421280001564590-20-007021
10-Q2019-11-12fiscal Q3 2019411100001564590-19-042533
10-Q2019-08-06fiscal Q2 2019411070001564590-19-028984
10-Q2019-05-02fiscal Q1 201941790001564590-19-015034
10-K2019-02-19fiscal FY 2018391240001564590-19-003191
10-Q2018-11-06fiscal Q3 201837940001564590-18-027097
10-Q2018-08-07fiscal Q2 201838960001564590-18-019644
10-Q2018-05-03fiscal Q1 201832650001564590-18-010492
10-K2018-02-22fiscal FY 2017321060001564590-18-002772
10-Q2017-11-02fiscal Q3 201728750001564590-17-020982
10-Q2017-08-03fiscal Q2 201728750001564590-17-015355
10-Q2017-05-10fiscal Q1 201728570001564590-17-010003
10-K2017-02-24fiscal FY 2016331080001564590-17-002434
10-Q2016-11-03fiscal Q3 201628750001564590-16-027173
10-Q2016-08-09fiscal Q2 201628750001193125-16-675953
10-Q2016-05-06fiscal Q1 201627550001193125-16-582026
10-K2016-02-29fiscal FY 2015321130001193125-16-485683
10-Q2015-11-06fiscal Q3 201524640001193125-15-370112
10-Q2015-08-12fiscal Q2 201525650001193125-15-288194
10-Q2015-05-15fiscal Q1 201526530001193125-15-190246
10-K2015-03-06fiscal FY 201430750001193125-15-081090
10-Q2014-11-13fiscal Q3 201426710001193125-14-410228
10-Q2014-08-14fiscal Q2 201426690001193125-14-310086

Inspect the source

Entity
Sage Therapeutics, Inc. / CIK 0001597553
Captured
2026-09-21T17:20:16.999Z
SEC response SHA-256
afd97550f2619e8ee699b816b1e9c9bfcb0395cfffc579f5c489401eae3ca58f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001597553.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))